Skip to content
Dispatch
Revision history

Enveda raises $311M Series E at $2B valuation to advance AI-discovered drugs into clinical trials

Original publish · no revisions.

← Back to article

Stories may contain errors. Dispatch is assembled with AI assistance and curated by human editors; despite the trust-score filter, mistakes happen. We correct publicly — every article links to its revision history. Nothing here is financial, legal, or medical advice. Verify before relying on any claim.

© 2026 Dispatch. No ads. No sponsorships. No paid placement. Reader-supported via Ko-fi.

Built by a person who cares about honest AI news.